HCW Biologics
HCWB
HCW Biologics (HCWB) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Maxim Group | Maintained | Buy | $5.00 from $2.00 | May 28, 2026 |
| Maxim Group | Maintained | Buy | $35.00 from $120.00 | May 29, 2025 |
| EF Hutton | Maintained | Buy | $9.00 | Apr 19, 2023 |
| EF Hutton | Maintained | Buy | $9.00 | Mar 30, 2023 |
| EF Hutton | Maintained | Buy | $9.00 | Mar 23, 2023 |
Frequently asked questions
What is the latest analyst rating on HCWB?
On May 28, 2026, Maxim Group maintained HCW Biologics at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.